JNGLX
Price
$92.44
Change
-$1.78 (-1.89%)
Updated
Aug 20 closing price
Net Assets
5.81B
RYHCX
Price
$108.85
Change
+$1.46 (+1.36%)
Updated
Aug 21 closing price
Net Assets
21.7M
Interact to see
Advertisement

JNGLX vs RYHCX

JNGLX vs RYHCX Comparison Chart in %
View a ticker or compare two or three
VS
JNGLX vs. RYHCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Hold and RYHCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5.81B vs. RYHCX (21.7M). JNGLX pays higher dividends than RYHCX: JNGLX (0.40) vs RYHCX (0.00). JNGLX was incepted earlier than RYHCX: JNGLX (28 years) vs RYHCX (25 years). RYHCX (2.43) is less costly to investors than JNGLX (0.81). RYHCX is a more actively managed with annual turnover of: 244.00 vs. JNGLX (30.00). JNGLX (2500) and RYHCX (2500) have matching initial minimum investment requirements. JNGLX annual gain was more profitable for investors over the last year : 34.62 vs. RYHCX (24.63). JNGLX return over 5 years is better than : 25.90 vs. RYHCX (9.12).
JNGLXRYHCXJNGLX / RYHCX
Total Expense Ratio0.812.3834%
Annual Report Gross Expense Ratio0.812.4333%
Fund Existence28 years25 years-
Gain YTD14.13815.47891%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets5.81B21.7M26,751%
Annual Yield % from dividends0.400.00-
Returns for 1 year34.6224.63141%
Returns for 3 years35.7631.94112%
Returns for 5 years25.909.12284%
Returns for 10 years89.0937.33239%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPIIX18.290.20
+1.11%
Timothy Plan International I
AMADX45.610.28
+0.62%
American Century Disciplined Value A
GMXPX29.520.17
+0.58%
Goldman Sachs Large Cp Val Insghts P
KSMVX10.270.05
+0.49%
Keeley Gabelli SMID Cap Value A
MSRRX57.550.23
+0.40%
MFS Research R2